[HTML][HTML] Role of estrogens in menstrual migraine

RE Nappi, L Tiranini, S Sacco, E De Matteis, R De Icco… - Cells, 2022 - mdpi.com
Migraine is a major neurological disorder affecting one in nine adults worldwide with a
significant impact on health care and socioeconomic systems. Migraine is more prevalent in …

Estrogen, migraine, and vascular risk

G Allais, G Chiarle, S Sinigaglia, G Airola… - Neurological …, 2018 - Springer
Migraine has a predilection for female sex and the course of symptoms is influenced by life
stage (presence of menstrual cycle, pregnancy, puerperium, menopause) and use of …

[HTML][HTML] Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the …

S Sacco, GS Merki-Feld, KL Ægidius, J Bitzer… - The journal of headache …, 2017 - Springer
Several data indicate that migraine, especially migraine with aura, is associated with an
increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of …

Effects of the menstrual cycle on neurological disorders

HJ Roeder, EC Leira - Current neurology and neuroscience reports, 2021 - Springer
Abstract Purpose of Review The menstrual cycle involves recurrent fluctuations in hormone
levels and temperature via neuroendocrine feedback loops. This paper reviews the impact …

Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine …

M Morotti, V Remorgida, PL Venturini… - European Journal of …, 2014 - Elsevier
Objective Evaluate patient satisfaction at 6-month treatment in women with symptomatic
rectovaginal endometriosis and migraine without aura with (progestogen-only contraceptive …

Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis

S Warhurst, CJ Rofe, BJ Brew, D Bateson… - …, 2018 - journals.sagepub.com
Background Migraine is highly prevalent in women (18%). Peak morbidity affects their most
productive years, coinciding with peak fertility. Hormonal contraception is often tailored for …

Menstrual migraine: a review of current and developing pharmacotherapies for women

G Allais, G Chiarle, S Sinigaglia… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Migraine is one of the most common neurological disorders in the general
population. It affects 18% of women and 6% of men. In more than 50% of women …

[HTML][HTML] Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?

RE Nappi, GS Merki-Feld, E Terreno… - The journal of headache …, 2013 - Springer
A significant number of women with migraine has to face the choice of reliable hormonal
contraception during their fertile life. Combined hormonal contraceptives (CHCs) may be …

Atogepant has no clinically relevant effects on the pharmacokinetics of an ethinyl estradiol/levonorgestrel oral contraceptive in healthy female participants

W Ankrom, J Xu, MH Vallee… - The Journal of …, 2020 - Wiley Online Library
The incidence of migraine is higher among women than men and peaks during the
reproductive years, when contraceptive medication use is common. Atogepant, a potent …

Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study

M Morotti, V Remorgida, PL Venturini… - European Journal of …, 2014 - Elsevier
Objective To evaluate the effect of a desogestrel progestogen-only pill (POP) compared to
continuous combined oral contraception (COC) on migraine patterns in women with …